Etoposide Supplier-Buyer Network — Trade Flow Analysis

Name: Etoposide Supplier-Buyer Trade Network Dataset — 237+ Indian Exporters, 17+ Importers, 122+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Etoposide supplier network, Etoposide buyers, pharmaceutical export India, Etoposide trade data

TransData Nexus

Etoposide

India Pharmaceutical Trade Intelligence

$10.8M237 Suppliers122 CountriesHS 30049045

ExportsIndia → UNITED STATES23.1%India → NETHERLANDS9.2%

ImportsGERMANY → India$492 UNITED STATES → India$402

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: EVERSANA LIFE

Who Supplies Etoposide? Top Manufacturers & Buyers 2026 — INTAS PHARMACEUTICALS LIMITED Leads | TransData Nexus | TransData Nexus

1INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the first-largest Etoposide exporter from India, with a market share of 18.6% and a total export value of $2.0M across 580 shipments. Their average shipment value of $3.5K is below the market average of $5.1K, reflecting a high-volume, competitive pricing strategy.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• EVERSANA LIFE SCIENCES SERVICES LLC — $965.4K across 278 shipments (47.9% of this supplier's total exports)

• AMERISOURCE HEALTH SERVICES — $302.5K across 87 shipments (15.0% of this supplier's total exports)

• EVERSANA LIFE SCIENCES SERVICES LLC — $295.6K across 85 shipments (14.7% of this supplier's total exports)

• TO THE ORDER — $261.9K across 75 shipments (13.0% of this supplier's total exports)

• ALLOGA FRANCE — $190.4K across 55 shipments (9.4% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (580 shipments) at a per-shipment value of $3.5K, indicating a broad distribution network with many smaller, regular orders.

2FRESENIUS KABI ONCOLOGY LIMITED

FRESENIUS KABI ONCOLOGY LIMITED is the second-largest Etoposide exporter from India, with a market share of 8.0% and a total export value of $866.0K across 126 shipments. Their average shipment value of $6.9K is above the market average of $5.1K, suggesting premium or bulk contract pricing.

FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. FRESENIUS KABI DEUTSCHLAND GMBH is the dominant customer, accounting for 53.7% of this supplier's tracked business. Top customers include:

• FRESENIUS KABI DEUTSCHLAND GMBH — $464.9K across 68 shipments (53.7% of this supplier's total exports)

• FRESENIUS KABI MALAYSIA SDN BHD — $171.8K across 25 shipments (19.8% of this supplier's total exports)

• FRESENIUS KABI TAIWAN LTD — $97.6K across 14 shipments (11.3% of this supplier's total exports)

• FRESENIUS KABI TAIWAN LTD — $65.9K across 10 shipments (7.6% of this supplier's total exports)

• FRESENIUS KABI SOUTH — $65.7K across 10 shipments (7.6% of this supplier's total exports)

Key Insight: FRESENIUS KABI ONCOLOGY LIMITED's per-shipment value of $6.9K is 35% above the market average of $5.1K, consistent with large-order contracts or value-added formulations.

3MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the third-largest Etoposide exporter from India, with a market share of 5.0% and a total export value of $543.6K across 7 shipments. Their average shipment value of $77.7K is above the market average of $5.1K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• CSP MYLAN IRELAND LIMITED — $271.6K across 3 shipments (50.0% of this supplier's total exports)

• CSP P O VIATRIS SANT — $141.4K across 2 shipments (26.0% of this supplier's total exports)

• CSP MYLAN IRELAND LT — $130.6K across 2 shipments (24.0% of this supplier's total exports)

• PHARMADOX HEALTHCARE — $4 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $77.7K is 1428% above the market average of $5.1K, consistent with large-order contracts or value-added formulations.

4VENUS REMEDIES LIMITED

VENUS REMEDIES LIMITED is the fourth-largest Etoposide exporter from India, with a market share of 3.3% and a total export value of $357.8K across 139 shipments. Their average shipment value of $2.6K is below the market average of $5.1K, reflecting a high-volume, competitive pricing strategy.

VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• P P — $140.8K across 55 shipments (39.4% of this supplier's total exports)

• C M C L — $80.6K across 31 shipments (22.5% of this supplier's total exports)

• PT M L — $50.1K across 19 shipments (14.0% of this supplier's total exports)

• A.S.A.S — $43.3K across 17 shipments (12.1% of this supplier's total exports)

• PT MEGA LIFESCIENCES — $43.0K across 17 shipments (12.0% of this supplier's total exports)

Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (139 shipments) at a per-shipment value of $2.6K, indicating a broad distribution network with many smaller, regular orders.

5MEDORBIS TRADE LLP

MEDORBIS TRADE LLP is the fifth-largest Etoposide exporter from India, with a market share of 3.0% and a total export value of $319.6K across 4 shipments. Their average shipment value of $79.9K is above the market average of $5.1K, suggesting premium or bulk contract pricing.

MEDORBIS TRADE LLP serves 1 named buyer in our database. ROPSOHN THERAPEUTICS SAS is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• ROPSOHN THERAPEUTICS SAS — $319.6K across 4 shipments (100.0% of this supplier's total exports)

Key Insight: MEDORBIS TRADE LLP's per-shipment value of $79.9K is 1472% above the market average of $5.1K, consistent with large-order contracts or value-added formulations.

6HETERO LABS LIMITED

HETERO LABS LIMITED is the fifth-largest Etoposide exporter from India, with a market share of 1.3% and a total export value of $141.8K across 6 shipments. Their average shipment value of $23.6K is above the market average of $5.1K, suggesting premium or bulk contract pricing.

HETERO LABS LIMITED serves 2 named buyers in our database. NA is the dominant customer, accounting for 80.5% of this supplier's tracked business. Top customers include:

• NA — $114.1K across 5 shipments (80.5% of this supplier's total exports)

• TO THE ORDER OF — $27.6K across 1 shipments (19.5% of this supplier's total exports)

Key Insight: HETERO LABS LIMITED's per-shipment value of $23.6K is 365% above the market average of $5.1K, consistent with large-order contracts or value-added formulations.

1United States

United States ranks as the first-largest destination for Etoposide imports from India, with a total trade value of $2.5M across 51 shipments — representing a 23.1% share of all Etoposide exports. The average shipment value of $49.0K is above the global average of $5.1K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Etoposide importers in United States: EVERSANA LIFE SCIENCES SERVICES,LLC is the largest buyer, accounting for 60.8% ($1.5M) of this market's total imports.

• EVERSANA LIFE SCIENCES SERVICES,LLC — $1.5M (60.8% of United States's total)

• AMERISOURCE HEALTH SERVICES — $507.8K (20.3% of United States's total)

• EVERSANA LIFE SCIENCES SERVICES LLC — $344.7K (13.8% of United States's total)

Key Insight: United States's per-shipment average of $49.0K (864% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Etoposide imports from India.

Primary Market

Secondary Market

2Netherlands

Netherlands ranks as the second-largest destination for Etoposide imports from India, with a total trade value of $993.3K across 97 shipments — representing a 9.2% share of all Etoposide exports. The average shipment value of $10.2K is above the global average of $5.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Etoposide importers in Netherlands: BROCACEF NL : HUB is the largest buyer, accounting for 30.3% ($301.3K) of this market's total imports.

• BROCACEF NL : HUB — $301.3K (30.3% of Netherlands's total)

• ALLOGA FRANCE — $235.4K (23.7% of Netherlands's total)

Key Insight: Netherlands's per-shipment average of $10.2K (102% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Netherlands is a key market for Etoposide imports from India.

Primary Market

Secondary Market

3France

France ranks as the third-largest destination for Etoposide imports from India, with a total trade value of $747.3K across 2 shipments — representing a 6.9% share of all Etoposide exports. The average shipment value of $373.6K is above the global average of $5.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Etoposide importers in France: CSP MYLAN IRELAND LIMITED is the largest buyer, accounting for 36.3% ($271.6K) of this market's total imports.

• CSP MYLAN IRELAND LIMITED — $271.6K (36.3% of France's total)

Key Insight: France's per-shipment average of $373.6K (7253% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Etoposide imports from India.

Primary Market

Secondary Market

4Colombia

Colombia ranks as the fourth-largest destination for Etoposide imports from India, with a total trade value of $485.1K across 3 shipments — representing a 4.5% share of all Etoposide exports. The average shipment value of $161.7K is above the global average of $5.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Etoposide importers in Colombia: ROPSOHN THERAPEUTICS SAS is the largest buyer, accounting for 69.1% ($335.3K) of this market's total imports.

• ROPSOHN THERAPEUTICS SAS — $335.3K (69.1% of Colombia's total)

Key Insight: Colombia's per-shipment average of $161.7K (3082% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Colombia is a key market for Etoposide imports from India.

Primary Market

Secondary Market

5Germany

Germany ranks as the fifth-largest destination for Etoposide imports from India, with a total trade value of $475.0K across 22 shipments — representing a 4.4% share of all Etoposide exports. The average shipment value of $21.6K is above the global average of $5.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Etoposide importers in Germany: FRESENIUS KABI DEUTSCHLAND GMBH is the largest buyer, accounting for 100.0% ($475.0K) of this market's total imports.

• FRESENIUS KABI DEUTSCHLAND GMBH — $475.0K (100.0% of Germany's total)

Key Insight: Germany's per-shipment average of $21.6K (325% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Germany is a key market for Etoposide imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Etoposide.
2.Flow Mapping: 237 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,129 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 122 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2,129 Verified Shipments

237 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Etoposide

Etoposide

Who Supplies Etoposide? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Etoposide? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Etoposide Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1INTAS PHARMACEUTICALS LIMITED

2FRESENIUS KABI ONCOLOGY LIMITED

3MYLAN LABORATORIES LIMITED

4VENUS REMEDIES LIMITED

5MEDORBIS TRADE LLP

6HETERO LABS LIMITED

From Indian Factories to Global Pharmacies — How Etoposide Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Etoposide Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Netherlands

3France

4Colombia

5Germany

People Also Ask — Etoposide Supplier & Trade Network

Etoposide Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology